基于 1 个已确定 T+90 收益的买入信号。收益基准:公布次日的收盘价。
Browse the detailed record of transactions filed by Hooper Anthony C. Director active across 5 companies, notably BeiGene, Ltd.. In total, 12 filings have been published. Split: 1 buy · 0 sell. Total volume traded: €97k. History available since 16 June 2021. The latest transaction was filed on 1 March 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 条申报中的 12 条
HOOPER ANTHONY C is a declarant linked to BeiGene, Ltd., Mannkind CORP, AMGEN INC, BeOne Medicines Ltd., and MANNKIND CORP, with the roles listed in the data block. He has 12 filings in total, and across the available sample of recent filings, buys amount to EUR 96950 and sells to EUR 0, over the period from 2016-02-01 to 2026-06-15, with the modal transaction nature shown as Attribution.